For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of MANGALAM DRUGS. For more details, see the MANGALAM DRUGS quarterly results and MANGALAM DRUGS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.0 |
No. of shares | m | 15.83 |
1 Week | % | -6.2 |
1 Month | % | -6.6 |
1 Year | % | -14.8 |
52 week H/L | Rs | 132.4/85.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
MANGALAM DRUGS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 182 | 60 | 175 | 197 | 173 | |
Low | Rs | 40 | 20 | 32 | 98 | 95 | |
Sales per share (Unadj.) | Rs | 124.0 | 158.9 | 243.0 | 284.9 | 235.2 | |
Earnings per share (Unadj.) | Rs | -5.1 | 5.2 | 17.7 | 12.4 | 0.8 | |
Diluted earnings per share | Rs | -5.1 | 5.2 | 17.7 | 12.4 | 0.8 | |
Cash flow per share (Unadj.) | Rs | -0.6 | 10.4 | 23.5 | 18.9 | 7.7 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 60.4 | 65.7 | 82.6 | 95.1 | 96.0 | |
Adj. book value per share | Rs | 60.4 | 65.7 | 82.6 | 95.1 | 96.0 | |
Shares outstanding (eoy) | m | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 | |
Price / Sales ratio | x | 0.9 | 0.3 | 0.4 | 0.5 | 0.6 | |
Avg P/E ratio | x | -21.9 | 7.7 | 5.9 | 11.9 | 166.8 | |
P/CF ratio (eoy) | x | -186.6 | 3.9 | 4.4 | 7.8 | 17.3 | |
Price / Book Value ratio | x | 1.8 | 0.6 | 1.3 | 1.5 | 1.4 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 1,758 | 635 | 1,639 | 2,331 | 2,118 | |
Total wages/salary | Rs m | 258 | 260 | 299 | 373 | 346 |
MANGALAM DRUGS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,963 | 2,516 | 3,847 | 4,511 | 3,723 | |
Other income | Rs m | 3 | 12 | 0 | 1 | 4 | |
Total revenues | Rs m | 1,967 | 2,528 | 3,847 | 4,512 | 3,727 | |
Gross profit | Rs m | 97 | 237 | 580 | 491 | 255 | |
Depreciation | Rs m | 71 | 82 | 92 | 102 | 110 | |
Interest | Rs m | 86 | 104 | 93 | 112 | 128 | |
Profit before tax | Rs m | -57 | 63 | 395 | 277 | 22 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 23 | -20 | 115 | 81 | 9 | |
Profit after tax | Rs m | -80 | 83 | 280 | 197 | 13 | |
Gross profit margin | % | 4.9 | 9.4 | 15.1 | 10.9 | 6.9 | |
Effective tax rate | % | -40.0 | -32.0 | 29.2 | 29.1 | 42.6 | |
Net profit margin | % | -4.1 | 3.3 | 7.3 | 4.4 | 0.3 |
MANGALAM DRUGS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,050 | 1,192 | 1,339 | 1,850 | 2,066 | |
Current liabilities | Rs m | 908 | 1,095 | 1,091 | 1,301 | 1,654 | |
Net working cap to sales | % | 7.2 | 3.9 | 6.5 | 12.2 | 11.1 | |
Current ratio | x | 1.2 | 1.1 | 1.2 | 1.4 | 1.2 | |
Inventory Days | Days | 5 | 13 | 6 | 2 | 1 | |
Debtors Days | Days | 328 | 580 | 515 | 376 | 456 | |
Net fixed assets | Rs m | 1,063 | 1,115 | 1,302 | 1,434 | 1,530 | |
Share capital | Rs m | 158 | 158 | 158 | 158 | 158 | |
"Free" reserves | Rs m | 798 | 881 | 1,150 | 1,347 | 1,361 | |
Net worth | Rs m | 957 | 1,039 | 1,308 | 1,506 | 1,520 | |
Long term debt | Rs m | 86 | 42 | 69 | 251 | 188 | |
Total assets | Rs m | 2,114 | 2,307 | 2,641 | 3,284 | 3,596 | |
Interest coverage | x | 0.3 | 1.6 | 5.2 | 3.5 | 1.2 | |
Debt to equity ratio | x | 0.1 | 0 | 0.1 | 0.2 | 0.1 | |
Sales to assets ratio | x | 0.9 | 1.1 | 1.5 | 1.4 | 1.0 | |
Return on assets | % | 0.3 | 8.1 | 14.1 | 9.4 | 3.9 | |
Return on equity | % | -8.4 | 7.9 | 21.4 | 13.1 | 0.8 | |
Return on capital | % | 2.8 | 15.4 | 35.5 | 22.1 | 8.8 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 69.6 | 59.4 | 39.1 | 47.6 | 25.7 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 1,366 | 1,496 | 1,506 | 2,148 | 958 | |
Fx inflow | Rs m | 423 | 919 | 1,421 | 1,407 | 1,078 | |
Fx outflow | Rs m | 1,372 | 1,499 | 1,507 | 2,150 | 978 | |
Net fx | Rs m | -949 | -580 | -85 | -744 | 100 |
MANGALAM DRUGS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 217 | 305 | 276 | 257 | 395 | |
From Investments | Rs m | -93 | -69 | -313 | -273 | -222 | |
From Financial Activity | Rs m | -114 | -235 | 27 | 30 | -166 | |
Net Cashflow | Rs m | 10 | 2 | -10 | 14 | 7 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Govardhan M Dhoot | COMP SEC: Geeta G Karira | YEAR OF INC: 1972 | BSE CODE: 532637 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare MANGALAM DRUGS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.